Clinical Pharmacokinetics Study on Pikamilone

NCT00940186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2009-07-15

No results posted yet for this study

Summary

Study on the phamacokinetics of Pikamilone in healthy Chinese subject and provide informations for further phase II study.

Conditions

  • Healthy

Sponsors & Collaborators

  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • D F Zhong, PH.D · Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Completion
2009-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940186 on ClinicalTrials.gov